The purpose of this single-arm longitudinal study is to describe accelerometry-estimated sleep and concurrently measured glycemic control at baseline and after initiating a hybrid closed loop insulin delivery system at 3 months, 6 months, and 9 months in adults with long standing type 1 diabetes (>10 years) and hypoglycemia unawareness. This evidence concerns the gene INS and type 1 diabetes mellitus.